The Cooper Companies(COO) - 2025 Q2 - Earnings Call Presentation

CooperCompanies Fiscal 2025 financial guidance | | | FY25 Guidance | | Organic Growth vs. FY24 | | | --- | --- | --- | --- | --- | --- | | e | Total | $4,107 - | $4,146 | 5% - 6% | | | u n e v e | CooperVision | $2,759 - | $2,786 | 6% - | 7% | | R | CooperSurgical | $1,347 - | $1,359 | 3.5% - | 4.5% | | S P E | Non-GAAP | $4.05 - | $4.11 | | | Notes: Sales $ in millions 1. Guidance updated 5/29/25. 2. Revenue growth is organic and non-GAAP EPS growth excludes FX. Organic growth is defined as constant curren ...